Nanotechnology-based Approaches for Breast Cancer

Author:

Prabha Shashi1,Kumar Panda Pritish2ORCID,Singh Sumita3,Ahmed Bahar1

Affiliation:

1. School of Pharmaceutical Education and Research, Department of Pharmaceutics, Jamia Hamdard (Deemed University), New Delhi, 110062, India

2. Department of Pharmaceutics, Haldia Institute of Pharmacy, Knowledge City, ICARE Complex, Haldia, West Bengal, 721657, India

3. Department of Pharmacy, Swami Vivekanand Subharti University, Meerut, U.P. India

Abstract

Abstract: One common cancer among women is breast cancer. Chemotherapy, radiation therapy, and surgery have historically been used as breast cancer treatments. Thanks to recent technological advancements, we have been able to progressively comprehend the complexity and heterogeneity of diseases, which has led to the development of more effective treatments for many conditions. Working with variably shaped nanoparticles, nanotechnology has recently enabled us to work on tumor targeting and drug delivery, and it has undoubtedly helped to reduce the spread and death of breast cancer. The efficacy of treatment for breast cancer can be increased by a variety of target therapies made possible by nanotechnology. The current review discusses the advantages and disadvantages of nanotechnology-based therapy for breast cancer while also highlighting the disease's current state. The article will provide an overview of the current strategy available for better treatment of breast cancer and aid in understanding the various drug delivery systems designed to provide effective treatment for the disease. By utilizing cutting-edge technologies and early screening, breast cancer fatalities can be decreased. Drug delivery methods based on nano carriers enable medication to reach the target site at the ideal concentration with the least amount of harmful side effects.

Publisher

Bentham Science Publishers Ltd.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3